Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment.

Journal article

Ma J. et al, (2024), Proceedings of the National Academy of Sciences of the United States of America, 121

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control.

Journal article

Wajja A. et al, (2024), The Lancet. Infectious diseases, 24, e78 - e79

Revaccination with BCG: does it work?

Journal article

McShane H., (2024), The Lancet. Infectious diseases

Exploring the ethics of tuberculosis human challenge models.

Journal article

Rohrig A. et al, (2023), Journal of medical ethics

Improving TB vaccine trial efficiency: A tough nut to crack.

Journal article

Mcshane H., (2023), The Journal of infectious diseases

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge.

Journal article

Stylianou E. et al, (2023), Frontiers in immunology, 14

BCG: Past, Present and Future Direction

Chapter

Morrison H. and McShane H., (2023), Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges: Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis, 171 - 195

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges.

Journal article

Morrison H. et al, (2023), Frontiers in immunology, 14

Healthy volunteer symptom profile following research bronchoscopy

Conference paper

Morrison H. et al, (2023), EUROPEAN RESPIRATORY JOURNAL, 62

The VALIDATE Network: Accelerating Vaccine Development for Tuberculosis, Leishmaniasis, Melioidosis and Leprosy

Chapter

Vermaak S. et al, (2023), Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges: Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis, 11 - 25

Load More